Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDKN2A - PI3K/mTOR Inhibitor NVP-BEZ235 and taxotere effects on prostate cancer xenograft tumors
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDKN2A - Arsenic effect on lung epithelial cell line
CDKN2A - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CDKN2A - Long-term adult survivors of glioblastoma: primary tumors
CDKN2A - Differentiating glioblastoma-initiating cells
CDKN2A - High-risk bladder cancer
CDKN2A - NCI-60 cancer cell line panel
CDKN2A - Oxidized low-density lipoprotein effect on LOX-1 overexpressing aortic endothelial cell line HAECT: time course
CDKN2A - High and low chromosomal instability phenotypes in stage II and III colorectal cancers
CDKN2A - Pretreatment breast needle biopsies of locally advanced breast cancer
CDKN2A - Staufen1 deletion effect on mRNA abundance in HeLa cells
CDKN2A - Saliva of pre-treatment pancreatic cancer patients
CDKN2A - Glioblastoma stem-like cell lines, glioblastomas, and glioma cell lines
CDKN2A - HMEC-1 endothelial cell line response to infection by Rickettsia prowazekii
CDKN2A - Ovarian normal surface epithelia and ovarian cancer epithelial cells
CDKN2A - NOR1 gene and EWS/NOR1 fusion gene overexpression
CDKN2A - CD133+ and CD133- glioblastoma-derived cancer stem cell lines
CDKN2A - p63 depletion effect
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on